Complete amino acid sequence of heavy chain variable regions derived from two monoclonal anti-p-azophenylarsonate antibodies of BALB/c mice expressing the major cross-reactive idiotype of the A/J strain by unknown
COMPLETE  AMINO  ACID  SEQUENCE  OF  HEAVY  CHAIN 
VARIABLE  REGIONS  DERIVED  FROM  TWO  MONOCLONAL 
ANTI-p-AZOPHENYLARSONATE  ANTIBODIES  OF  BALB/c 
MICE  EXPRESSING  THE  MAJOR  CROSS-REACTIVE 
IDIOTYPE  OF  THE  A/J  STRAIN 
BY  KATHERYN MEEK,*  DEBRA JESKE,*  M.  SLAOUI,*  OBERDAN LEO,* 
JACQUES URBAIN,*  AND J.  DONALD CAPRA* 
From the *Department of Microbiology, The University of Texas Health Science Center, 
Dallas, Texas 75235; and *Laboratoire de Physiologie Animale,  Faculty of Sciences, Universite 
Libre de Bruxelles,  Rhode-St-Genese, B1640 Belgium 
Over two decades ago, it was shown that antibodies possessed unique antigenic 
characteristics (I, 2). These determinants were found to be associated first with 
the Fab, and later the Fv portion of the antibody molecule, the portion eventually 
proven to be responsible for each antibody's antigenic specificity (3, 4). Some of 
these variable region markers, later termed idiotypes, were shown to be inherited, 
first in rabbits (5) and then in other species (6).  These results were interpreted 
to mean that different individuals possessed different genetic repertoires for the 
generation of immune responses (7).  Subsequently, when it was postulated that 
idiotypes might be instrumental in the regulation of immune responses, these 
markers became a major focus in immunology (8). 
The  cross-reactive  idiotype  (CRI) 1 of A/J  mice has  served  as  a  model  for 
inherited idiotypic systems in an inbred strain. The hapten, p-azophenylarsonate, 
when coupled to keyhole limpet hemocyanin (KLH-Ars), produces a strong anti- 
hapten response when injected into A/J mice (9). Structural and serologic studies 
using antibodies  from  mice  inoculated  in  this  manner  have  shown  that  this 
response is generated from only a very limited number of variable region genes 
which give rise to three families of anti-arsonate antibodies (10-12). These three 
families have been termed Ars A, Ars B, and Ars C. The cross-reactive idiotypes 
associated with the Ars A and Ars C families have been termed CRIA and CRIc, 
respectively. 
The CRI defined by using a polyclonal rabbit antisera raised against A/J anti- 
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1070  J. ExP. MED. © The Rockefeller University Press • 0022-1007/84/10/1070/17 $1.00 
Volume 160  October 1984  1070-1086 MEEK  ET  AL.  1071 
arsonate antibodies and then extensively absorbed on preimmune A/J immuno- 
globulin, has been exclusively associated with the Ars A family of antibodies (10). 
Furthermore,  amino  acid  sequence  studies,  as  well  as  chain  recombination 
experiments comparing several anti-arsonate antibodies that vary in their degree 
of expression of the CRI, suggest that the structures responsible for this idiotype 
are located in the heavy chain (13,  14). 
In contrast to A/J mice, when BALB/c mice are inoculated in precisely the 
same  manner,  this  idiotype  is  generally  undetectable.  While  BALB/c  mice 
produce a  strong anti-arsonate response, serologic and structural studies have 
shown that antibodies of the Ars A  family are not produced (10).  Instead, the 
bulk of the response is in the Ars-B and Ars-C families (15).  Breeding studies 
first demonstrated that the expression of the CRI was a genetic trait inherited 
in a classical Mendelian manner as if it were an autosomal dominant gene linked 
to  the lgh  gene complex  (16).  Later,  using  the  relatively few mouse strains 
carrying a defined kappa light chain polymorphism (17), the requirement for an 
appropriate kappa chain gene for the formation of antibodies bearing the CRI 
was demonstrated as well (18). 
The gene encoding the Vn  segment of the Ars A  family of antibodies has 
recently been sequenced and evidence has been presented that this gene is absent 
in  the  BALB/c  genome (19,  20).  This  provides  a  sound explanation  for the 
absence of the  CRI  in  BALB/c  mice and  provides  strong evidence that  the 
structural correlates of the Ars CRIA are located in the variable segment of the 
heavy chain. 
There  have  been,  however,  several  disquieting  reports  that  BALB/c  mice 
express the CRIA under certain experimental conditions (21-23).  For example, 
it has been shown that idiotype-positive antibodies can be elicited in  BALB/c 
mice that are first primed with anti-CRI  antibodies and then inoculated with 
Ars-KLH  (23).  In  fact,  these  idiotype-positive antibodies  can  occasionally be 
produced in BALB/c mice that are inoculated with Ars-KLH alone. Hybridomas 
derived from such mice have recently been constructed  e and serologic analyses 
of these monoclonal antibodies have confirmed the results of previous cellular 
and serum studies. 
This  study presents  the  complete heavy chain  variable  region amino  acid 
sequences of two  of these CRI-positive  BALB/c  monoclonal antibodies.  The 
results show that while their D segments are remarkably similar to the D segments 
of a  number  of Ars-A  monoclonal  antibodies  previously  sequenced  in  our 
laboratory, the VH segments (1-98) are strikingly different from any of the Ars 
A family VH segments. In addition, rather than the usual JH2 gene segment used 
by most CRI+ A/J anti-Ars antibodies, one of the BALB/c hybridoma products 
uses a Jia 1 gene segment, while the other uses a Jn4. These data imply that this 
D  segment in  the context of an appropriate  light chain may, in  itself, confer 
expression of the CRI in certain molecules that use totally unrelated VH and JH 
segments. 
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Materials and  Methods 
Pur~cation  of Hybridoma Products.  Hybridoma 9A5  was  prepared by the fusion of 
spleen cells from a BALB/c mouse immunized first with rabbit anti-CRI and then with 
Ars-KLH  with  the  non-secreting hybrid plasmacytoma  cell  line  Spl-43  as  previously 
described.  2 Hybridoma 22B5 was ~,repared similarly, but from a  mouse receiving only 
Ars-KLH, as previously described.  These hybridomas were injected into CAF~ mice for 
the collection of ascites fluid. Hybridoma products were purified from the resulting ascites 
fluid by affinity chromatography as previously described (24). Briefly, the ascites fluid was 
bound  onto  a  Sepharose  4-B  column  that  had  been  conjugated  with  arsonilic acid- 
derivatized human gamma globulin.  Purified antibody was eluted with 0.2  M arsonilic 
acid, dialyzed against deionized, distilled H~O and lyophilized. 
Heavy and Light Chain Preparation.  To dissociate heavy and light chains for amino 
acid sequencing, whole purified hybridoma products were completely reduced and alky- 
lated by the addition of 2-mercaptoethanol and then iodoacetic acid. The heavy and light 
chains were then separated on a Biogel A5M column in 5 M guanidine HCI. Desalting 
was accomplished by dialysis against 0.25 M NH4OH. The heavy and light chains were 
lyophilized and subjected to sequence analysis. 
The heavy chains of both hybridoma products had a pyroglutamic acid as the amino 
terminal residue, thus leaving the amino terminus unavailable for the Edman reaction. 
The  heavy chains  were,  therefore,  citraconylated and  deblocked  using  pyroglutamic 
aminopeptidase and again subjected to automated amino acid sequence analysis (25, 26). 
Preparation and Sequencing of Heavy Chain CNBr Fragments.  The  two  hybridoma 
products HP 9A5 and HP 22B5 were cleaved at methionine residues by incubation with 
cyanogen bromide in  100 M excess over lysine residues in 70% formic acid for 24 h at 
room temperature. 
In the case of HP 9A5, the heavy chain variable region was cleaved at only one position, 
which resulted in two disulfide-bonded peptides. By gel filtration on a Sephadex G-100 
column in 5 M guanidine HCI, these two peptides, extending from positions  1-48 and 
49-142, eluted in one peak. After desalting and iyophilization, these two peptides were 
dissociated from each other by complete reduction and alkylation. Separation was achieved 
by gel filtration on a Sephadex G-75 column in 0.25 M NH4OH. The peptide extending 
from position 49-142 was sequenced to position 84 in the automated sequencer. 
In the case of HP 22B5, the heavy chain variable region was cleaved at four positions, 
resulting in  five peptides.  The peptide extending from position  109-265,  which  was 
disulfide bonded to several disulfide-bonded fragments of the light chain, eluted in the 
column's exclusion volume. By subjecting the resulting protein pool to complete reduction 
and alkylation, the heavy chain peptide was separated from the light chain peptides by 
using a Sephadex G-100 column in 5 M guanidine HCI. This peptide was sequenced in 
the automated sequencer from positions 109-125. 
The two disulfide-bonded peptides extending from positions  1-34 and  92-108  co- 
eluted with two other peptides--one extending from position 396-437, and one extending 
from position 49-91. By subjecting this entire pool to complete reduction and alkylation, 
the peptide extending from position 92-108 and the peptide extending from position 1- 
34 could each be isolated by using a G-50 Sephadex column in 0.25  M NH4OH. The 
other two peptides (49-91 and 396-437) co-eluted. The peptide extending from position 
92-108 was sequenced entirely on the automated sequencer. 
The  peptide  extending  from  position  35-48  was  isolated  from  a  separate  CNBr 
digestion of the whole molecule on a Sephadex G-50 column in 0.25 M NH4OH. This 
peptide was sequenced entirely in the automated sequencer. 
Preparation and Sequencing of Tryptic Peptides.  CNBr fragments 1-48 of 9A5 and 1- 
34  of HP  22B5  were  digested  with  TPCK  trypsin  (Worthington  Biochemical Corp., 
Freehold, N  J). The resulting peptides were isolated by reverse phase high pressure liquid 
chromatography (HPLC) on an RP-300 column, as previously described (11). 
CNBr  fragments  49-142  of HP  9A5  and  49-91  and  396-437  of HP  22B5  were 
digested  with  TPCK trypsin.  The resulting peptides were  separated by ion exchange 
chromatography on a Sephadex-SP column in 8 M urea and a 0 to 0.2 M KCI gradient MEEK ET  AL.  1073 
(11), or by HPLC on an RP-300 column. CNBr fragment 49-142 of HP 9A5 was also 
digested with chymotrypsin. The resulting peptides were similarly separated by HPLC on 
an RP-300 column. 
Sequence analysis of the peptides resulting from tryptic and chymotryptic digestion of 
CNBr peptides  made  it possible to obtain  the  complete amino acid  sequence  of both 
molecules. 
Sequencing Methodology.  Automated amino acid sequence analysis was performed using 
a Beckman 890C, 890D (Beckman Instruments, Inc., Palo Alto, CA) or Applied Biosystems 
gas phase sequencer. 0.25  M or 0.1  M Quadrol programs were used with the Beckman 
instruments. The PROTFA and TFAV programs were used with the Applied Biosystems 
machine.  Phenylthiohydantoin  amino acid derivatives were identified  by HPLC  using 
Waters NovaPak RCM C-18 and Waters CN columns (Waters Associates, Inc., Milford, 
MA) for identification. The amino acid compositions of selected peptides were determined 
on a Beckman System 6300 amino acid analyzer. 
Measurement of Antigen Binding.  Ars binding was quantitated  in two solid-phase ra- 
dioimmunoassays (RIAs). The first was a  standard,  indirect-binding  RIA in  which the 
binding of serial dilutions of hybridoma products was detected with  l~SI-labeled  rabbit 
anti-mouse Ig. The second was a competition RIA. Serial dilutions of unlabeled hybridoma 
products (HPs) were first added to microtiter wells that had been coated previously with 
either Ars-BSA or Ars-KLH and were allowed to compete for binding to antigen with a 
standard quantity (10 ng) of a  125I-labeled anti-Ars hybridoma 93G7, added to the wells 
shortly thereafter. 
Chain Recombination.  Chain recombinations were performed by the method of Giles 
et al. (27). Briefly, heavy and light chains were dissociated by partial reduction with 0.1 
M 2-mercaptoethanol in 0.5 M Tris, pH 8.3, and alkylated with 0.15 M iodoacetamide. 
After dialysis against Tris-buffered saline, pH 8.2,  to remove the excess reducing and 
alkylating reagents, heavy and light chains were separated by gel filtration on a Bio-Gel 
A-5M column (Bio-Rad Laboratories, Richmond, CA) equilibrated with 5 M guanidine- 
HCI. The completeness of separation was verified by SDS-polyacrylamide gel electropho- 
resis. Homologous and heteroiogous recombinations were performed by mixing the heavy 
and  light  chain  pools  in  1:1  molar  ratio  and  dialyzing  against  Tris-buffered  saline. 
Molecules in the molecular weight range 300,000 to 100,000 daltons were isolated by gel 
filtration on a column of Sephacryl S-300 (Pharmacia, Piscataway, NJ) equilibrated with 
phosphate-buffered saline, pH 7.4. 
Southern Filter Hybridization.  The method  for Southern  filter hybridization (28) of 
mouse liver and hybridoma DNA was modified from that previously described by Sims et 
al (19). DNA was digested with Eco RI, Sac I, or Xba I and fractionated on a 0.6% agarose 
gel in TBE (0.089 M Tris, 0.089 M boric acid, 0.002 M EDTA, pH 8.0). The DNA was 
denatured  in the gel for 2 h  in a solution of 0.5  N  NaOH in  1.5  M NaCI. It was then 
neutralized for 2 h in 0.5 M Tris buffer, pH 7.5, containing 1.5 M NaCI, before transfer 
of the DNA to nitrocellulose in 20× SSC (1.5 M NaCI, 0.15 M sodium citrate, pH 7.2). 
The filters were baked under vacuum at 80°C  and prewashed at 42°C  for 24 h  in  a 
solution  containing  5×  SSC,  0.02%  polyvinylpyrrolidone, 0.02%  Ficoll, 0.02%  bovine 
serum albumin, 100/~g]ml herring sperm DNA, and 50% formamide. Hybridization was 
carried out at 42°C for 48 h in the same solution with the addition of 50/~g/ml poly (rA) 
and the nick-translated (29) probe at a final concentration of 1 ×  10  n cpm/ml. After a 48- 
h  hybridization, the filters were washed sequentially with 3× SSC at room temperature, 
then  1×  SSC and 0.1×  SSC for  1 h  each at 42°C.  Kodak XAR-5 film was exposed at 
-70°C. A Barn HI/Eco RI fragment containing theJn3 andJn4 genes was isolated from 
a 0.6% agarose gel after electrophoresis of a subclone of BALB/c Jn genomic DNA kindly 
provided by Dr. P. Tucker (Univ. of Texas Health Science Center, Dallas). 
Results and  Discussion 
BALB/c  CRI+ Anti-Ars Antibodies Employ Light Chains Homologous to Those of 
the  Ars A  Family  but  Their  VH  Segments  Are  Vastly  Different.  Amino  terminal 1074  COMPLETE  AMINO  ACID  SEQUENCE 
sequence analysis of the light chains of both hybridoma products showed that 
the first 25 residues of both light chains are identical to A/J, CRI+, Ars-A family 
light chains (30) with the exception of one residue at position  17  in HP 22B5 
where an alanine is substituted for the aspartic acid found in most Ars-A family 
light  chains.  This  light  chain  has  not  been  observed in  other  BALB/c  anti- 
arsonate antibodies, but has been seen in BALB/c anti-oxazolone antibodies and 
in antioarsonate antibodies of the congenic strain C.AL 20, which carries the A 
strain VH segment genes on a BALB/c background (31). 
The complete heavy chain variable region amino acid sequence of these two 
molecules is compared to that of the CRI+, Ars-A prototype molecule HP 93G7 
in  Fig.  1.  The dissimilarities between these molecules and HP 93G7  are quite 
apparent.  Of the 98  amino acid residues in the heavy chain variable segment 
(positions 1-98), HP 9A5 differs in 44. HP 22B5 differs in 43. This represents 
~55% homology, which is no more homology than would be expected between 
any two randomly selected murine heavy chain variable segments. These data 
suggest that  the  BALB/c  proteins  derive from germline VH  gene(s) that are 
clearly different from the  germline VH  segment that  gives rise  to  the Ars-A 
family. On the other hand, the homology between the VR segments of these two 
molecules is substantial, with only 16 differences in 98 residues (84% homology). 
Expression of Idiotypic Determinants  and Antigen  Binding on Recombined Mole- 
cules.  The  recombined  molecules were  tested  for  the  presence of idiotypic 
determinants as defined by rabbit anti-CRI. When heavy and light chains from 
93G7 and 9A5 were recombined, the extent of idiotypy was dependent on the 
choice of heavy chain (Fig. 2A), a result consistent with previous observations in 
the Ars-A family (14). The light chains of 93G7 and 9A5 were interchangeable, 
however, suggesting that the light chain used by 9A5 is functionally identical (at 
least in its idiotypic properties) to those used by the Ars-A family. Additionally, 
as shown by the antigen binding data in Fig. 2B, the light chains of 93G7 and 
9A5 were interchangeable in their ability to restore antigen binding to a given 
heavy chain. In this series of experiments, as in  those reported previously for 
HP 101F11, an A/J CRI+ hybridoma with diminished antigen binding (32), the 
heavy chain determines the avidity for arsonate. 
Two Similar BALB/c VH Segments Are Encoded by Separate Germline Genes.  In 
order to ascertain whether the two BALB/c hybridomas are derived from the 
same or different germline Vu gene segments, a series of Southern filter hybrid- 
izations were performed in  which a J  segment probe was used to detect rear- 
ranged genes. Fig. 3 illustrates the results obtained after Eco RI digestion. The 
probe revealed a single 6.7-Kb component in BALB/c liver DNA (lane A) that 
represents the germline configuration of the JH cluster. In previous studies, this 
germline  component  has  been  observed  in  about  half  of  the  anti-arsonate 
hybridomas studied. The BALB/c fusion partner, (lane B), does not contain the 
6.7-Kb germline component, but does contain a 5.8-Kb component that hybrid- 
izes to the probe.  It has been previously shown that this represents a  nonpro- 
ductive rearrangement of a  Vn gene segment. The hybridoma 22B5  (lane C) 
gave two restriction fragments of 10.8 Kb and 5.8 Kb. The latter fragment (5.8 
Kb) co-migrated with, and presumably represents, the Sp2 restriction fragment. 
The former (10.8  Kb),  therefore, represents the productively rearranged Vn 9
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FIGURE 2.  ExpressionoftheCRI(A)andantigenbinding(B)byanti-Arsantibodiesgenerated 
in chain recombination experiments. Homologous and heterologous combinations of light and 
heavy chains from HP 93G7 (the prototype A]J CRI+ anti-arsonate antibody) and HP 9A5 
(one of the  BALB/c CRI+  anti-arsonate antibodies) are compared using the recombined 
hybridoma products and isolated light and heavy chains as controls. (A) Inhibition by recom- 
,25  bined molecules of a fixed quantity (10 ng) of  I-labeled HP 93G7 by slightly less than an 
equivalent amount of rabbit anti-CRI antiserum. 50 ng amounts of isolated chains were used 
as controls. (B) Competition between recombined molecules of 125I-labeled  HP 93G7 (10 ng) 
for  binding  to  Ars-BSA-coated polyvinyl plates.  Isolated chains  corresponding in  molar 
amounts of 1,250 ng of whole immunoglobulin were used as controls all of which showed 
negligible competition. 
gene  segment  of hybridoma  22B5.  Lane  D  shows  the  results  with  hybridoma 
9A5.  Three  restriction fragments are noted,  one at  22  Kb,  one at 6.7  Kb, and 
one  at  5.8  Kb.  Initially,  the  6.7-Kb  fragment  was  thought  to  represent  the 
germline  JH  cluster  (see  lane  A)  while  the  5.8-Kb  fragment  was  thought  to 
represent the Sp2 restriction fragment. Thus,  the 22-Kb fragment in hybridoma 
9A5 most likely represents the productively rearranged  VH segment gene. Since 
the difference between the sizes of the restriction fragments in hybridomas 9A5 MEEK ET AL.  1077 
FIGVRE 3.  Southern  filter hybridization  of anti-Ars hybridoma  DNA digested  with Eco RI. 
Digests of DNA from  BALB/c  liver (A), SP2/0-Ag-14 (B), 9A5 (C), and 22B5 (D) are blotted 
with a Js-J4 probe prepared from  BALB/c  genomic  DNA. The positions of molecular  weight 
markers  (linear  oligomers  of lambda dv21 DNA,  Boehringer-Mannheim,  Indianapolis, IN) are 
indicated. 
and 22B5 is greater than the difference betweenJnl andJH4 (the twoJn segments 
utilized by these hybridomas (Fig.  1), these data support the view that these two 
hybridomas are encoded by different VH gene segments. 
This  interpretation  was  supported  by  two  further  experiments  (data  not 
shown). A  digestion  with the restriction enzyme Sac  I  again revealed a  single 
restriction  fragment  in  the  BALB/c  germline  (4.4  Kb),  a  single  restriction 
fragment in  the  Sp2  DNA  (4.5  Kb),  two restriction  fragments in  hybridoma 
22B5  (13.0 and 4.5  Kb), and three in hybridoma 9A5 (11.5, 4.8, and 4.5  Kb). 
These  data  supported  the  interpretation  that  both  the  BALB/c  hybridomas 
contained the Sp2 nonproductively rearranged gene (4.5 Kb) but did not support 
the initial  conclusion that hybridoma 9A5 had retained the BALB/c germline 
gene, as the 4.4-Kb germline restriction fragment was not seen. However, since 
the difference between the restriction fragments in the two BALB/c hybridomas 
was greater (and in the wrong direction) than would be anticipated from the J1- 
J4  usage,  the interpretation of the Eco  RI  experiment, that  two different VH 
gene segments were being utilized in  the BALB/c hybridomas was supported 
fully. 
Experiments done with the enzyme Xba I also confirmed this conclusion. Both 
of the BALB/c  hybridomas contained a  restriction fragment that co-migrated 
with  the  Sp2  nonproductively rearranged  VH  gene  segment,  and  again  the 
productively rearranged Vn gene segments in the two BALB/c hybridomas were 
not consistent with J l/J4 usage of the same germline Vn gene segment. Rather, 
the results were more consistent with the conclusion that different germline Vn 
gene segments had been utilized by the two hybridomas. 
Areas Within the VH Segments Bearing Structural Homology with Ars A Vu Segments 
Probably Do Not Affect  Idiotype Expression.  Within  the VH  segments there are 1078  COMPLETE AMINO ACID SEQUENCE 
three portions of these two molecules which bear significant structural similarity 
to HP 93G7.  The three molecules are all fairly homologous between positions 
18-30,  35-47,  and 92-98.  However, these areas are framework regions and 
contain the cysteine residues responsible for the Vn internal disulfide bond (18- 
30, 92-98) or make contact with light chains (35-47). The amino acid sequence 
in  these  areas  tends  to  be  highly  conserved  throughout  all  families of Vn 
segments. Furthermore, in extensive comparisons of A/J Ars-A CRI+ and CRI- 
molecules, differences in  these areas have never correlated with  presence or 
absence of the CRI (11, 32). It is, therefore, unlikely that any amino acid residues 
within these areas contribute significantly if at all to idiotype expression. 
Classically, one would expect structures responsible for idiotypy to be confined 
to hypervariable regions. Interestingly, both the first and second hypervariable 
regions of HP 9A5 and HP 22B5 are quite distinct from those of the prototype 
molecule, 93G7.  In the second hypervariable region, these molecules all share 
an isoleucine and asparagine in positions 51  and 52.  But again, comparisons of 
A/J  CRI+  and  CRI-  molecules have  never  correlated  differences in  these 
positions to idiotype expression. Likewise, these molecules share phenylalanine, 
lysine,  and  glycine at  positions  64-66,  but  similarly  there  is  no  compelling 
evidence that these residues affect idiotype expression (11, 32). 
Vn Segments of the BALB/c CRI+ Anti-Arsonate  Antibodies Probably Represent a 
Separate  Vn Subgroup.  When trying to assign  these antibodies to  one of the 
three anti-arsonate families, it became apparent that these molecules were mark- 
edly dissimilar from all of the families. Serologically, they are different from Ars- 
A in that they lack the 91A3 markerfl They are also serologicaily different from 
Ars-B  and  Ars-C  in  that  they are  strongly positive  in  the  classic  CRI  assay. 
Structurally,  they  are  obviously  different  from  Ars-A,  as  has  already  been 
discussed, but they are just as dissimilar in this regard to both the Ars-B and Ars- 
C families. In fact, the only anti-arsonate antibody bearing significant homology 
to these molecules is HP 45-165, an A/J CRI- anti-arsonate antibody described 
by Margolies et al. (33). Only the amino terminal amino acid sequence has been 
determined for this  antibody's heavy chain,  but  there is  only one difference 
between it and HP 22B5, and three differences between it and HP 9A5 in the 
first 35 positions.  Unlike the BALB/c CRI+ antibodies, the light chain of 45- 
165 is unrelated to the Ars-A family of light chains (33). 
Furthermore, assignment of the Vn segments of these BALB/c antibodies to 
one of the five VH subgroups is also extremely difficult because of the dissimilarity 
of these  molecules  with  any  murine  Vn  segments  sequenced  to  date.  The 
structure of the VH segments are so dissimilar to any previously sequenced Vu 
segments that it is probable that DNA probes made to either 9A5 or 22B5 will 
detect a new family of germline Vn gene segments. Therefore, we suggest that 
these heavy chains may represent a separate VH subgroup, which we have termed 
V.VI. 
BALB/c,  CRI+ Anti-Ars Antibodies Employ the Same or Similar  DH Segment as 
Their A/J Ars A Counterparts but Use Different Jn Segments.  Fig. 4 compares the 
D segments of these two BALB/c, CRI+ anti-Ars antibodies with three A/J Ars- 
A, strongly CRI+ antibodies, to the germline sequence of the BALB/c D segment 
FL16.1  sequenced by Kurosawa et al. (34). The homology of the D segments of MEEK  ET  AL.  1079 
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FIGURE 4.  Comparison  of the  amino acid  sequence  of the  D  segments  of three  CRI+ 
hybridomas  of the A/J strain [93G7(19), 16.7(11), 36-65(29)] and the two BALB/c hybridomas 
that bear the  A/J  cross-reacting  idiotype  (9A5,  22B5).  A  straight line indicates  identical 
residues. Note that four of the five sequences differ in position 5 from the BALB/c FL16.1 D 
segment. 
these two BALB/c CRI+ antibodies to the D segments of the A]J antibodies is 
striking. HP 22B5's D segment matches the germline sequence FL16.1  exactly. 
The D segment of HP 9A5 has a single substitution, a glycine for the germline 
residue serine at position  104. However, an identical substitution exists in most 
of the A/J CRI+ antibodies. An attractive explanation for this particular high 
frequency substitution,  as has been suggested, is that the A]J strain has in its 
germline glycine in  place  of serine at  that  position  in  its  counterpart of the 
FL16.1  D  segment (11).  The serine-glycine interchange in  HP  9A5  probably 
represents a  somatic mutation and may contribute to the CRI+ nature of this 
molecule (see below), In terms of homology to the prototype molecule HP 93G7 
(discounting V/D and D/J junctional positions) HP 9A5's  D  segment is  100% 
homologous and HP 22B5's is 83% homologous. There is also no difference in 
D segment length between these two molecules and HP 93G7. 
In contrast to the D  segments, the J. segments of these BALB/c hybridoma 
products have little in  common with their A]J counterparts. The majority of 
A/J CRI+ antibodies employ Jn2 (11), whereas JH4 is utilized by HP 22B5, and 
HP 9A5 utilizes JH 1. 
The Structure Imparting  Expression of the CRI in HP 22B5 and HP 9A5 Is Most 
Likely Located in the Dn Segment.  The most plausible conclusion from these data 
is  that  the  structure  responsible  for  the  heavy  chain's  contribution  to  the 
expression of this idiotype is located in the D segment. The other two possible 
explanations for these results are (a) that the structural correlate of the idiotype 
is actually in the Ars-A light chain, or (b) that some portion of the Vn segments 
of 22B5 and 9A5 mimic three-dimensionally a portion of the Ars-A VH segment. 
Overwhelming evidence from chain recombination experiments (13,  14) makes 
the first of these alternatives highly unlikely. The second of these possibilities is 
not attractive considering the degree of differences between the first and second 
hypervariable regions of 22B5 and 9A5 and the Ars-A family (only 40% homol- 
ogy), but nevertheless, cannot be entirely ruled out. 
From computer-derived three-dimensional models of Ars-A antibodies, it has 
been  suggested that  the  majority of the  D  segment is  on  the  surface of the 
molecule and, therefore, may be exposed well enough to solvent to be antigenic 
in itself (30).  The residues comprising this particular D segment are extremely 1080  COMPLETE  AMINO  ACID  SEQUENCE 
hydrophobic, which may also contribute to antigenicity. We propose that the VH 
segments we have described, like their Ars-A counterparts, along with an appro- 
priate light chain, can place this Dn segment into a  specific three-dimensional 
configuration  that  is  most  probably  the  structure  primarily  contributing  to 
idiotype expression in HP 22B5 and HP 9A5, and probably CRIA antibodies, as 
well. This interpretation is in direct contradiction to results obtained not only in 
our laboratory but also from several other laboratories that have mapped the 
gene responsible for idiotype expression specifically to  the VH gene segment. 
One of these studies, using recombinant inbred strains that had BALB/c variable 
region genes to the left of VDEx but A/J VH gene segments to the right of VnEx, 
showed conclusively that mice lacking the gene encoding the Ars-A Vn segment 
but possessing the Jri, Cn, and likely D as well as the light chain of A/J mice, did 
not express  the CRI  (20).  This  implies either that  (a)  this  D  segment is also 
encoded to  the  left of VoEx or  that  (b)  the second  VH  appropriate  for CRI 
expression in conjunction with the appropriate  D segment was also deleted in 
these mice so that no appropriate VH segment gene was available for use in the 
anti-arsonate response, or that (c) in an anti-arsonate response, clones producing 
anti-arsonate antibodies with the appropriate  D  segment and the appropriate 
light chain  for CRI  expression are generally only expanded if the Ars-A Vn 
segment is present as well. 
The first of these explanations is feasible, but there is no evidence at this time 
to support the hypothesis that D gene segments are interspersed among the VH 
gene  segments.  This  explanation  also  does  not  address  the  issue  that  CRI + 
antibodies similar to HP 9A5 and HP 22B5 have not been seen in A/J mice even 
though both strains presumably have the genetic information to produce them. 
The second explanation is not attractive since the VH segments of HP 9A5 and 
HP 22B5 have been observed in both the A/J and BALB/c strains, so it is highly 
unlikely that a recombinant inbred strain derived from them would lack this VH 
gene. This leaves the third explanation as the most feasible, but the question 
remains: Why are molecules like HP 9A5 and HP 22B5 not regularly employed 
in either the A/J or BALB/c response to KLH-Ars? 
Under Normal Circumstances B Cell Clones Producing  These Antibodies May Not 
Be Expanded Possibly Because of Their Weaker Antigen Binding Characteristics.  The 
production of this second type of CRI+ antibody may be down regulated either 
at  the  T  cell  level  or  through  gene  regulation.  This  would  explain  reports 
showing that B cell clones producing CRI+ anti-Ars antibodies are present in 
classically CRI- strains, but these clones may not be expanded and their products 
not generally expressed in the serum anti-Ars response (21, 22). The reason for 
this  preferential  selection  is  not  understood,  but  there are  obviously several 
possibilities. One would be that these antibodies may not bind arsonate as well 
as the Ars-A family in the A]J strain or the Ars-C family in the BALB/c strain 
and, therefore, cannot compete with these strong arsonate binders for antigenic 
stimulation. In fact, neither HP 9A5 nor HP 22B5 binds arsonate as well as HP 
93G7 in a standard inhibition assay (Fig. 2B). By first expanding CRI+ clones in 
the BALB/c  strain  with  an  initial  injection of anti-CRI,  these clones, now  in 
greater numbers, may favorably compete for antigen during an anti-Ars response, 
thus explaining the expression of the CRI in BALB/c mice in this instance. The MEEK ET AL.  1081 
fact  that  CRI+  antibodies  similar  to  HP  22B5  and  HP  9A5  have  not  been 
identified in the A/J strain even though A/J mice presumably have the genetic 
capability to  produce them,  is  consistent with  the idea  that  clones producing 
these antibodies are suppressed because of weak antigen binding and not because 
of presence or  absence of the  idiotype.  However,  more data are  needed to 
address this issue.  It is  likely that other factors in addition to antigen binding 
characteristics govern the expression of molecules like HP 22B5  and HP 9A5 
during an immune response to arsonate. 
Idiotypes Are Not Necessarily Subgroup Markers.  These data also create another 
parodox in that they contradict the notion that antibodies which share unique 
serologic characteristics are almost always very similar to one another structurally 
as well and, therefore, are generally of the same subgroup. These data suggest 
that idiotypy may in some instances be determined by only a small fraction of an 
entire molecule, in  that antibodies employing entirely different VH subgroups 
express the major CRI of the A/J strain. This idea is not new, as it was actually 
postulated even before the discovery of the molecular mechanisms of antibody 
synthesis which, as we now know, allow for the utilization of different D or Jn 
segments with the same VH segment or vice-versa as is demonstrated in this case. 
Indeed, in the early 1970's, the observation that similar idiotypes could be found 
in antibodies of differing V region subgroup led to some of the early notions of 
gene interaction (35-40). 
Anti-Anti-ldiotype Antibodies (Ab3) Are Not Necessarily Equivalent to the Original 
Antibody (Abl) and Have Implications Concerning the Modulation  of the Immune 
Response.  These data also broaden our understanding of the idiotype cascade 
phenomenon. Briefly, it has been well documented that an immunologic response 
is induced by immunization with anti-idiotypic (Ab2) antibodies. The resulting 
antibodies (Ab3) may or may not express the idiotype of the original idiotype- 
bearing antibody (Abl) and may or may not share the antigenic specificity of the 
original antibody. It has been postulated that Ab3 that are equivalent to Abl in 
antigenic specificity and idiotypy would be closely related structurally to Abl as 
well.  This  study shows that this  is  not necessarily true--and again, raises  the 
question of why certain antibodies are expressed when the immune system is 
manipulated, but are not generally expressed during a normal immune response. 
Other implications arise from these data as well. In envisioning an idiotypic 
regulatory system, one must now take into account the fact that antiidiotypic 
antibodies may have the capability to react with and affect antibodies of different 
VH  subgroups.  One  could  theorize  from  this  the  possibility  that  a  specific 
antiidiotypic antibody may have the potential to regulate antibodies with entirely 
different binding specificities. This would imply that the number of regulatory 
antibodies required for modulation of any possible  immune response  may be 
much smaller than the number of specific antibodies in an individual's antibody 
repertoire. Also, if one ascribes to the idea that antiidiotypic antibodies provide 
internal selective pressure for the maintenance of certain variable region genes 
(41),  this example of idiotype sharing between antibodies employing different 
Vn segments would imply that a  single antiidiotypic antibody could maintain 
antibodies of multiple binding specificities. 
Similarly, this idea that idiotype expression may result from the presence of a 1082  COMPLETE  AMINO  ACID  SEQUENCE 
very small part of a  molecule's structure may help in the understanding of the 
structural moiety that imparts idiotypic specificity to T  cell populations. Further- 
more, one could surmise that any one specific T  cell clone may very well be able 
to interact with more than one B cell clone. In fact, this observation of shared 
idiotypy between  vastly  different  molecules is  consistent with  recent reports 
showing that idiotype bearing T  cells do not transcribe the corresponding VH 
gene segment responsible for antibodies bearing the same idiotype (42).  Since 
the structures imparting idiotypy to  T  cells are different gene products from 
their B cell counterparts, these structures are most likely significantly different 
structurally even though they may behave similarly serologically. As the struc- 
tures of T  cell idiotypes are determined, it would seem most probable that the 
structural equivalent of these idiotypes will represent only a very small percentage 
of  an entire molecule, which is very likely considerably different from an antibody 
molecule bearing a serologically indistinguishable idiotype. 
This  difference between T  cell  and  B  cell  idiotypes would imply separate 
evolutionary paths  for the development of T  and B  cell functions and would 
suggest less interdependence between the two. Therefore, the sharing of sero- 
logic determinants between B and T  cells might be construed as coincidental 
and not important in  the modulation of the immune response.  However, the 
majority  of  functional  studies  indicate  that  idiotypes  do,  indeed,  modulate 
immune responses (41), so it is possible that serologically similar, but structurally 
dissimilar molecules, may actually evolve and function separately, but in coordi- 
nation with one another, each having the capability to affect the other's expres- 
sion. 
Structural Basis of the CRL  Fig. 5 represents a schematic summary of the gene 
segments used in the construction of anti-arsonate hybridomas in the A/J and 
BALB/c strain, all of which bear the CRI.  In several previous studies, the light 
chains of most of these hybridomas have been interchanged without any detect- 
able variation in either the expression of the CRI or the binding to the hapten, 
p-azophenylarsonate. Thus, the degree of idiotype expression and the strength 
of interaction with hapten, are directly attributable  to variations in  the heavy 
chain. As can be seen from Fig. 5, two different VH subgroups (gene segments) 
are employed. The typical Ars A hybridomas of the A/J strain utilize the VHV 
VII  D_H.H  J._HH  Hybridoma 
VH'~  ~,,.~.,,.  jH  1  U9A5 
93G7 
FL 16.1  ........... JH2  123E6 
j~  IZ4E1  16.'/" 
10tFtl  VH~[ "  'tJH4  U22B5 
FIGURE 5.  Schematic summary of gene segments used in the construction of anti-arsonate 
hybridomas of the A/J or BALB/c strain, all of which bear the cross-reacting idiotype. In each 
instance,  where  they have been  tested,  the  light chains  of these hybridomas  appear  inter- 
changeable. The VHV and VnVI subgroups differ in ~45% of their sequences. JH1, Ju2, and 
JH4 differ in ~40% of their positions. The only apparent common feature of these molecules 
is the FL16.1-1ike D segment. MEEK  ET  AL.  1083 
germline gene segment.  In all  instances studied, these derive from the same 
germline VH segment. The BALB/c hybridomas derive from two closely related 
gene segments that we have termed VHVI. They differ from the VnV sequence 
in over 45% of their amino acid positions.  A single hybridoma has been identified 
in the A/J strain which is idiotype negative, but that likely derives from a similar 
VHVI germline gene. All hybridomas appear to utilize  a variant of the FL16.1 
D gene segment, but three different  JH gene segments have been detected. One 
BALB/c hybridoma (9A5) uses JH1, another (22B5)  uses Jn4.  The typical  A/J 
hybridomas (93G7,  123E6,  124E1,  and 16.7) utilize JH2, but an occasional  A/J 
hybridoma utilizes JH4 (101 F 11 ) (41 ). In all three instances in which a JH segment 
other than JH2 is used (9A5-JH1,  101F11,  and 22B5-JH4), binding to hapten is 
considerably weaker than when a JH2 gene segment is utilized.  However, all of 
these molecules are positive  for the  major cross-reacting idiotype of the  A/J 
strain. Since their Vn gene segments are in toto over 45%  different, and their 
JH gene segments are varied and are over 40%  different, their only apparent 
common feature is the "variant" FL16.1  D segment. Thus, these data provide 
strong evidence that the FL16.1  D segment, in the context of an appropriate 
light chain, is the structure primarily responsible for the expression of the major 
cross-reacting idiotype of the A/J strain. 
Summary 
The primary structure of A/J anti-p-azophenylarsonate (anti-Ars)  antibodies 
expressing the major A-strain cross-reactive idiotype (CRIA) has provided impor- 
tant insights into issues of antibody diversity and the molecular basis of idiotypy 
in this important model system. Until recently, this idiotype was thought to be 
rarely, if ever, expressed in  BALB/c mice. Indeed, it  has been reported that 
BALB/c mice lack the heavy chain variable segment (VH) gene that is utilized by 
the  entire  family  of anti-Ars  antibodies  expressing  the  A/J  CRI.  Recently, 
however, it  has  been possible  to  elicit  CRIA+,  Ars binding antibodies in  the 
BALB/c strain by immunizing first with anti-CRI and then with antigen. Such 
BALB/c, CRIA+  anti-Ars antibodies can be induced occasionally  with antigen 
alone. 
VH  region amino acid sequences are  described for two  CRIA+  hybridoma 
products derived from BALB/c mice. While remarkably similar to each other, 
their VH segments (1-98) differ from the VH segments of A/J CRIA+, anti-Ars 
antibodies in over 40 positions.  Rather than the usual JH2 gene segment used by 
most A/J CRIA+ anti-Ars antibodies, one BALB/c CRIA+ hybridoma utilizes a 
JH1 gene segment, while the other uses aJH4. However, the D segments of both 
of the  BALB/c antibodies are remarkably homologous to  the  D segments of 
several A/J CRIA+ antibodies sequenced previously, as are the amino terminal 
amino acid sequences of their light chair, s. 
These data  imply that  BALB/c  mice express the  A/J  CRIA by  producing 
antibodies with  very similar,  if not  identical,  light  chain  and  heavy chain D 
segments, but in  the context of different VH and JH gene segments than their 
A/J  counterparts.  The  results  document that  molecules that  share  serologic 
specificities can have vastly different primary structures. 1084  COMPLETE  AMINO  ACID  SEQUENCE 
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